http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114129732-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate | 2021-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114129732-B |
| titleOfInvention | Use of NADPH oxidase 2 inhibitor in the preparation of medicine |
| abstract | The invention relates to the use of an NADPH oxidase 2 inhibitor in the preparation of medicines, and more particularly to the application of an NADPH oxidase 2 inhibitor in the preparation of medicines for preventing and/or treating NAFLD. The medicament is used for preventing and/or treating non-alcoholic fatty liver disease; the medicament is used for preventing and/or treating non-alcoholic fatty liver disease induced and/or aggravated by high carbohydrates. The present invention adopts NADPH oxidase 2 inhibitor, which can effectively prevent and/or treat non-alcoholic fatty liver disease. |
| priorityDate | 2021-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 140.